Company Profiles

driven by the PitchBook Platform

Edison (Pharmaceuticals)

Description

Developer of redox drugs designed to discover new approaches to human health and disease. The company's redox drugs detects defects in the mitochondrial proteins, enabling healthcare professionals to treat mitochondrial diseases are genetic disorders.

2005

Founded

PRIVATE

Status

11-50

Employees

Later Stage VC

Latest Deal Type

$50M

Latest Deal Amount

$87.9M

Total Amount Raised

Description

Developer of redox drugs designed to discover new approaches to human health and disease. The company's redox drugs detects defects in the mitochondrial proteins, enabling healthcare professionals to treat mitochondrial diseases are genetic disorders.

Website:

www.edisonpharma.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Drug Discovery

Primary Office

350 North Bernardo Avenue Mountain View, CA 94043United States +1 (650) 641-9200
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Edison (Pharmaceuticals)'s full profile, request a free trial.

Edison (Pharmaceuticals) Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Edison (Pharmaceuticals) Investors (5)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Berg and Berg EnterprisesVenture CapitalMinority000 0000000 0000
Dainippon Sumitomo PharmaLimited Partner000 0000000 0000
Individual InvestorAngel (individual)Minority000 0000000 0000
Mitsui Global InvestmentCorporate Venture CapitalMinority000 0000000 0000
Morningside GroupVenture CapitalMinority000 0000000 0000
Berg and Berg Enterprises Venture Capital
Dainippon Sumitomo Pharma Limited Partner
Individual Investor Angel (individual)
Mitsui Global Investment Corporate Venture Capital
Morningside Group Venture Capital

Edison (Pharmaceuticals) Executive Team (12)

NameTitleBoard
Seat
Contact
Info
Guy Miller Ph.DChief Executive Officer & Chairman
James GibsonChief Financial Officer
Rebecca Shortle JDDirector, Intellectual Property
Martin Thoolen Ph.DChief Drug Development Officer
William Shrader Ph.DSenior Vice President, Innovation
Guy Miller Ph.D Chief Executive Officer & Chairman
James Gibson Chief Financial Officer
Rebecca Shortle JD Director, Intellectual Property
Martin Thoolen Ph.D Chief Drug Development Officer
William Shrader Ph.D Senior Vice President, Innovation

Edison (Pharmaceuticals) Board Members (1)

NameRepresentingRoleSinceContact
Info
Guy Miller Ph.DEdison (Pharmaceuticals)Chief Executive Officer & Chairman000 0000
Guy Miller Ph.D Chief Executive Officer & Chairman Edison (Pharmaceuticals)
Request full access to PitchBook